1. 15-Deoxy-Δ12,14-Prostaglandin J2Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway
   Xin Liu et al, 2015, PPAR Research CrossRef
2. Ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma
   LUFANG CHEN et al, 2015 CrossRef
3. 125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
   Peng-Hui Hu et al, 2016, WJG CrossRef
4. Lipopolysaccharide promotes angiogenesis in mice model of HCC by stimulating hepatic stellate cell activation via TLR4 pathway
   Yi Lu et al, 2017 CrossRef
5. Contribution of pericyte paracrine regulation of the endothelium to angiogenesis
   A. Caporali et al, 2017, Pharmacology & Therapeutics CrossRef
6. The significance of intertumor and intratumor heterogeneity in liver cancer
   Jinping Liu et al, 2018, Exp Mol Med CrossRef
7. Nervous system and primary liver cancer
   Seogsong Jeong et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
8. Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis
   Seogsong Jeong et al, 2018, Hepatol Int CrossRef
9. Platelet-Derived Growth Factor-D Enables Liver Myofibroblasts to Promote Tumor Lymphangiogenesis in Cholangiocarcinoma
   Massimiliano Cadamuro et al, 2018, Journal of Hepatology CrossRef
10. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies
    Stefania Cannito et al, 2018, IJMS CrossRef
11. Predictive Value of Diminished Serum PDGF-BB after Curative Resection of Hepatocellular Cancer
    Bibek Aryal et al, 2019, Journal of Oncology CrossRef
12. Indazole-Cl inhibits hypoxia-induced cyclooxygenase-2 expression in vascular smooth muscle cells
    Choa Park et al, 2019 CrossRef
13. null
    Arthur Zimmermann, 2016 CrossRef
14. null
    Arthur Zimmermann, 2016 CrossRef
15. Mechanisms of hepatocellular carcinoma progression.
    Olorunseun O Ogunwobi et al, 2019, World J Gastroenterol CrossRef
16. Immunological landscape and immunotherapy of hepatocellular carcinoma
    Jesús Prieto et al, 2015, Nat Rev Gastroenterol Hepatol CrossRef
17. Proangiogenic factors in the development of HCC in alcoholic cirrhosis
    Mariana V. Machado et al, 2015, Clinics and Research in Hepatology and Gastroenterology CrossRef
18. Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis
    Xing Lv et al, 2016, Tumor Biol. CrossRef
19. null
    Arthur Zimmermann, 2017 CrossRef
20. null
    Arthur Zimmermann, 2017 CrossRef
21. Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics
    Quirino Lai et al, 2019, Cancers CrossRef
22. Human adipose-derived stem cell spheroids incorporating platelet-derived growth factor (PDGF) and bio-minerals for vascularized bone tissue engineering
    Jinkyu Lee et al, 2020, Biomaterials CrossRef
23. null
    David Roife et al, 2020 CrossRef
24. Neuropilin-1 promotes primary liver cancer progression by potentiating the activity of hepatic stellate cells
    Zhi‑Chao Xu et al, 2017, Oncol Lett CrossRef
25. The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
    Puchun Er et al, 2020, Aging CrossRef
26. Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma
    Nataša Pavlović et al, 2020 CrossRef
27. Vascularization and osteogenesis in ectopically implanted bone tissue-engineered constructs with endothelial and osteogenic differentiated adipose-derived stem cells
    Jelena G Najdanović et al, 2021, WJSC CrossRef
28. null
    Ravikiran Tekupalli et al, 2022 CrossRef
29. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials
    Ahmad Khan et al, 2022, Bioengineering CrossRef
30. Genetic Analysis of Platelet-Related Genes in Hepatocellular Carcinoma Reveals a Novel Prognostic Signature and Determines PRKCD as the Potential Molecular Bridge
    Xiangyu Li et al, 2022, Biol Proced Online CrossRef
31. Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity
    Cho-Won Kim et al, 2022, Mol.Cells CrossRef
32. Deciphering the possible reciprocal loop between hepatic stellate cells and tumor cells in the tumor microenvironment of the liver
    Devaraj Ezhilarasan et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
33. Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma
    Asmaa Y. Abuhamad et al, 2023, IJMS CrossRef
34. Prognostic stratification based on HIF-1α signaling for evaluating hypoxia status and immune landscape in hepatocellular carcinoma
    Hongkai Zhuang et al, 2023, J Big Data CrossRef
35. Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review
    Leszek Kraj et al, 2024, Cancers CrossRef
36. Mass Spectrometry-Based Multi-omics Analysis Reveals Distinct Molecular Features in Early and Advanced Stages of Hepatocellular Carcinoma
    Mingzhu Fan et al, 2024, Heliyon CrossRef